Up-regulation of adhesion molecule expression and induction of TNF-α on vascular endothelial cells by antibody against human parvovirus B19 VP1 unique region protein

Clinica Chimica Acta

Volumn 395, Issue 1-2, 2008, Pages 77-83

  Tzang, Bor Show ^a   Tsai, Chun Chou ^a   Chiu, Chun Ching ^a,b   Shi, Jing Yu ^a   Hsu, Tsai Ching ^a  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

Author keywords

Adhesion molecule; Anti 2 glycoprotein I antibody (anti 2GPI); Anti phospholipid syndrome (APS); Endothelial cell; Human parvovirus B19 (B19); VP1 unique region protein (VP1u)

Indexed keywords

CELL ADHESION MOLECULE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HLA DR3 ANTIGEN; IMMUNOGLOBULIN G ANTIBODY; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MITOGEN ACTIVATED PROTEIN KINASE P38; RECOMBINANT PROTEIN; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; VIRUS PROTEIN;

ANTIPHOSPHOLIPID SYNDROME; ARTICLE; AUTOIMMUNITY; CELL CULTURE; CYTOKINE PRODUCTION; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PARVOVIRUS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RABBIT; UPREGULATION;

ANIMALS; CAPSID PROTEINS; CELL ADHESION MOLECULES; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; HUMANS; IMMUNOGLOBULIN G; NITRIC OXIDE SYNTHASE TYPE II; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; PHOSPHORYLATION; RABBITS; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

ORYCTOLAGUS CUNICULUS; PARVOVIRUS;

EID: 47749095519     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2008.05.012     Document Type: Article

References (44)

1. Cossart Y.E., Field A.M., Cant B., and Widdows D. Parvovirus-like particles in human sera. Lancet 1 (1975) 72-73
2. Corcoran A., and Doyle S. Advances in the biology, diagnosis and host-pathogen interactions of parvovirus B19. J Med Microbiol 53 (2004) 459-475
3. Young N.S., and Brown K.E. Parvovirus B19. N Engl J Med 350 (2004) 586-597
4. Anderson S., Momoeda M., Kawase M., and Kajigaya S Young N.S. Peptides derived from the unique region of B19 parvovirus minor capsid protein elicit neutralizing antibodies in rabbits. Virology 206 (1995) 626-632
5. Modrow S., and Dorsch S. Antibody responses in parvovirus B19 infected patients. Pathol Biol (Paris) 50 (2002) 326-331
6. Zadori Z., Szelei J., Lacoste M.C., et al. A viral phospholipase A2 is required for parvovirus infectivity. Dev Cell 1 (2001) 291-302
7. Dorsch S., Leibisch G., Kaufmann B., et al. The VP1 unique region of parvovirus B19 and its constituent phospholipase A2-like activity. J Virol 76 (2002) 2014-2018
8. Canaan S., Zadori Z., Ghomashchi F., et al. Interfacial enzymology of parvovirus phospholipases A2. J Biol Chem 279 (2004) 14502-14508
9. Lu J., Zhi N., Wong S., and Brown K.F. Activation of synoviocytes by the secreted phospholipase A2 motif in the VP1-unique region of parvovirus B19 minor capsid protein. J Infect Dis 193 (2006) 582-590
10. Kawase M., Momoeda M., Young N.S., and Kajigava S. Most of the VP1 unique region of B19 parvovirus is on the capsid surface. Virology 211 (1995) 359-366
11. Musiani M., Manaresi E., Gallinelal G., et al. Immunoreactivity against linear epitopes of parvovirus B19 structural proteins. Immunodominance of the amino-terminal half of the unique region of VP1. J Med Virol 60 (2000) 347-352
12. Hsu T.C., and Tsay G.J. Human parvovirus B19 infection in patients with systemic lupus erythematosus. Rheumatology (Oxford) 40 (2001) 152-157
13. Lehmann H.W., von Landenberg P., and Modrow S. Parvovirus B19 infection and autoimmune disease. Autoimmun Rev 2 (2003) 218-223
14. Von Landenberg Philipp, Lehmann H.W., and Modrow S. Human parvovirus B19 infection and antiphospholipid antibodies. Autoimmun Rev 6 (2007) 278-285
15. Loizou S., Cazabon J.K., Walport M.J., Tait D., and So A.K. Similarities of specificity and cofactor dependence in serum antiphospholipid antibodies from patients with human parvovirus B19 infection and from those with systemic lupus erythematosus. Arthritis Rheum 40 (1997) 103-108
16. Chou T.N., Hsu T.C., Chen R.M., Lin L.I., and Tsay G.J. Parvovirus B19 infection associated with the production of anti-neutrophil cytoplasmic antibody (ANCA) and anticardiolipin antibody (aCL). Lupus 9 (2000) 551-554
17. von Landenberg P., Lehmann H.W., Knoll A., et al. Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection. Arthritis Rheum 48 (2003) 1939-1947
18. Lehmann H.W., Plentz A., Von Landenberg P.h.i.l.i.p.p., Muller-Godeffroy E., and Modrow S. Intravenous immunoglobulin treatment of four patients with juvenile polyarticular arthritis associated with persistent parvovirus B19 infection and antiphospholipid antibodies. Arthritis Res Ther 6 (2004) R1-R6
19. Kalt M., and Gertner E. Antibodies to beta 2-glycoprotein I and cardiolipin with symptoms suggestive of systemic lupus erythematosus in parvovirus B19 infection. J Rheumatol 28 (2001) 2335-2336
20. Loizou S., Cazabon J.K., Walport M.J., Tait D., and So A.K. Similarities of specificity and cofactor dependence in serum antiphospholipid antibodies from patients with human parvovirus B19 infection and from those with systemic lupus erythematosus. Arthritis Rheum 40 (1997) 103-108
21. Tzang B.S., Tsay G.J., Lee Y.J., Li C., Sun Y.S., and Hsu T.C. The association of VP1 unique region protein in acute parvovirus B19 infection and antiphospholipid antibody production. Clinica Chimica Acta 378 (2007) 59-65
22. Tzang B.S., Lee Y.J., Yang T.P., et al. Induction of antiphospholipid antibodies and antiphospholipid syndrome-like autoimmunity in naive mice with antibody against human Parvovirus B19 VP1 unique region protein. Clinica Chimica Acta 382 (2007) 31-36
23. Lim W., Crowther M.A., and Eikelboom J.W. Management of antiphospholipid antibody syndrome: a systematic review. JAMA 295 (2006) 1050-1057
24. Blank M., Cohen J., Toder V., and Shoenfeld Y. Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies. Proc Natl Acad Sci U S A 88 (1991) 3069-3073
25. Pierangeli S.S., and Harris E.N. Clinical laboratory testing for the antiphospholipid syndrome. Clin Chim Acta 357 (2005) 17-33
26. Bas de laat H., Derksen R.H., and de Groot P.G. beta2-glycoprotein I, the playmaker of the antiphospholipid syndrome. Clin Immunol 112 (2004) 161-168
27. Ma K., Simantov R., Zhang J.C., Silverstein R., Hajjar K.A., and McCrae K.R. High affinity binding of beta 2-glycoprotein I to human endothelial cells is mediated by annexin II. J Biol Chem 275 (2000) 15541-15548
28. Meroni P.L., Raschi E., Testoni C., and Borghi M.O. Endothelial cell activation by antiphospholipid antibodies. Clin Immunol 112 (2004) 169-174
29. George J., Blank M., Levy Y., et al. Differential effects of anti-beta2-glycoprotein I antibodies on endothelial cells and on the manifestations of experimental antiphospholipid syndrome. Circulation 97 (1998) 900-906
30. Raschi E., Testoni C., Borghi M.O., Fineschi S., and Meroni P.L. Endothelium activation in the anti-phospholipid syndrome. Biomed Pharmacother 57 (2003) 282-286
31. Cho C.S., Cho M.L., Chen P.P., et al. Antiphospholipid antibodies induce monocyte chemoattractant protein-1 in endothelial cells. J Immunol 168 (2002) 4209-4215
32. Meroni P.L., Ronda N., De Angelis, Grossi C., Raschi E., and Borghi M.O. Role of anti-beta2 glycoprotein I antibodies in antiphospholipid syndrome. Vitro and In Vivo Studies. Clin Rev Allergy Immunol vol. 32 (2007) 67-74
33. Vega-Ostertag M., Casper K., Swerlick R., Ferrara D., Harris E.N., and Pierangeli S.S. Involvement of p38 MAPK in the up-regulation of tissue factor on endothelial cells by antiphospholipid antibodies. Arthritis Rheum 52 (2005) 1545-1554
34. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65 (1983) 55-63
35. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
36. Towbin H., Staehelin T., and Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheet: procedure and some applications. Proc Natl Acad Sci U S A 76 (1979) 4350-4354
37. Miranda-Carus M.E., Askanase A.D., Clancy R.M., et al. Anti-SSA/Ro and anti-SSB/La autoantibodies bind the surface of apoptotic fetal cardiocytes and promote secretion of TNF-alpha by macrophages. J Immunol 165 (2000) 5345-5351
38. Turesson C. Endothelial expression of MHC class II molecules in autoimmune disease. Curr Pharm Des 10 (2004) 129-143
39. Simantov R., Lo S.K., Gharavi A., Sammaritano L.R., Salmon J.E., and Silverstein R.L. Antiphospholipid antibodies activate vascular endothelial cells. Lupus 5 (1996) 440-441
40. Chan E., Winston B.W., Uh S.T., et al. Evaluation of the role of mitogen-activated protein kinases in the expression of inducible nitric oxide synthase by IFN-g and TNF-α in mouse macrophages. J Immunol 162 (1999) 415-422
41. Da Silva J., Pierrat B., Mary J.L., and Lesslauer W. Blockade of p38 mitogen-activated protein kinase pathway inhibits inducible nitricoxide synthase expression in mouse astrocytes. J Biol Chem 272 (1997) 28373-28380
42. Barash J., Dushnitzki D., Barak Y., Miron S., and Hahn T. Tumor necrosis factor (TNF)alpha and its soluble receptor (sTNFR) p75 during acute human parvovirus B19 infection in children. Immunol Lett 88 (2003) 109-112
43. Magro C.M., Nuovo G., Ferri C., Crowson A.N., Giuggioli D., and Sebastiani M. Parvoviral infection of endothelial cells and stromal fibroblasts: a possible pathogenetic role in scleroderma. J Cutan Pathol 31 (2004) 43-50
44. Vega-Ostertag M., Harris E.N., and Pierangeli S.S. Intracellular events in platelet activation induced by antiphospholipid antibodies in the presence of low doses of thrombin. Arthritis Rheum 50 (2004) 2911-2919